Cholesterols are fundamental molecules for animals. Belonging to sterols class, these organic molecules take role on the composition of cell membranes, maintaining fluidity and integrity. Raised serum levels are highly associated with increased risk of stroke and heart disease. The World Health Organization points that one third of ischaemic heart disease can be attributed to high cholesterol (HC). The concern about treatment and prevention of HC and its consequences is global, once it is present in both developing and developed word as a risk factor for other health complications. This website explores a 2015 Medical Breakthrough regarding a new drug called PCSK9 inhibitors, which is assigned to be a good lowering-cholesterol medicament.

What the future holds for this drug?

Further studies are needed to strengthen evidence for some suggested clinical benefits, as stroke and cardiovascular disease. Those outcomes are already been assessed in current studies but full cardiovascular impact is unknown. Side effects were also reported, including nasopharyngitis, injection site reactions (PCSK9 inhibitors are given by subcutaneous injection one or two times per month), allergy, flu and itching, even so the drug is considered well-tolerated.
It is an expensive drug (cost could run $7.000 - $12.000 per year) but seems to be a good new for millions, but the personal lifestyle is still an important adjunct fundamentally linked with the maintenance of good cholesterol levels.

Quit smoking!
Eat low fat/salt diet! 
Exercise!

If cholesterol still remains high, drugs can be used to help!